Literature DB >> 12519421

A survey of dopamine agonist withdrawal policy in UK endocrinologists treating patients with prolactinomas.

S Mehmet, J K Powrie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12519421     DOI： 10.1046/j.1365-2265.2003.01678.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  1 in total

1.  Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas.

Authors:  E Sala; P Bellaviti Buttoni; E Malchiodi; E Verrua; G Carosi; E Profka; G Rodari; M Filopanti; E Ferrante; A Spada; G Mantovani
Journal:  J Endocrinol Invest       Date:  2016-05-31       Impact factor: 4.256
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.